Works matching AU Van der Meer, P. B.

Results: 9

Antiseizure medication in patients with meningioma: a retrospective cohort study on the long-term impact on depression, anxiety and neurocognitive functioning.

Published in:

Journal of Neuro-Oncology, 2025, v. 174, n. 1, p. 227, doi. 10.1007/s11060-025-05025-w

By:

Laribi, L.;
Scheepens, J. C. C.;
Zamanipoor Najafabadi, A. H.;
Vos, M. J.;
van Furth, W. R.;
Peerdeman, S. M.;
Taphoorn, M. J. B.;
Van der Meer, P. B.;
Koekkoek, J. A. F.;
Biermasz, N. R.;
Boele, F. W.;
Dirven, L.;
Klein, M.;
Moojen, W. A.;
Reijneveld, J. C.;
Verstegen, M. J. T.

Publication type:

Article

P14.49 Prescription preferences of antiepileptic drugs in brain tumor patients: an international survey.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii47, doi. 10.1093/neuonc/noab180.162

By:

Meer, P B van der;
Dirven, L;
Bent, M J van den;
Preusser, M;
Taphoorn, M J B;
Ruda, R;
Koekkoek, J A F

Publication type:

Article

P12.01 The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii30, doi. 10.1093/neuonc/noab180.103

By:

Opijnen, M P van;
Meer, P B van der;
Dirven, L;
Fiocco, M;
Kouwenhoven, M C M;
Bent, M J van den;
Taphoorn, M J B;
Koekkoek, J A F

Publication type:

Article

OS10.8.A The effectiveness of antiepileptic drug duotherapies in glioma patients: a multicenter observational cohort study.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii14, doi. 10.1093/neuonc/noab180.046

By:

Meer, P B van der;
Dirven, L;
Fiocco, M;
Vos, M;
Kouwenhoven, M C M;
Bent, M J van den;
Taphoorn, M J B;
Koekkoek, J A F

Publication type:

Article

OS3.5 Prescription medications in glioma patients and the prevalence of depression, anxiety and subjective cognitive impairment.

Published in:

Neuro-Oncology, 2019, v. 21, p. iii9, doi. 10.1093/neuonc/noz126.029

By:

Meer, P B van der;
Taphoorn, M J B;
Bent, M J van den;
Dirven, L;
Koekkoek, J

Publication type:

Article

OS3.1 Antiepileptic drugs and their association with depression, anxiety and subjective cognitive impairment in glioma patients.

Published in:

Neuro-Oncology, 2019, v. 21, p. iii8, doi. 10.1093/neuonc/noz126.025

By:

Meer, P B van der;
Taphoorn, M J B;
Bent, M J van den;
Dirven, L;
Koekkoek, J A F

Publication type:

Article

P05.65 The caregiver burden in meningioma: long-term results and its effects on caregiver's health-related quality of life, anxiety and depression.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii318, doi. 10.1093/neuonc/noy139.391

By:

Najafabadi, A H Zamanipoor;
Meer, P B van der;
Boele, F W;
Reijneveld, J C;
Taphoorn, M J B;
Klein, M;
Furth, W R van;
Dirven, L;
Peerdeman, S M;
Group, The Netherlands Meningioma Research

Publication type:

Article

P05.64 The disease burden of meningioma patients: long-term results on work productivity and healthcare consumption.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii318, doi. 10.1093/neuonc/noy139.390

By:

Najafabadi, A H Zamanipoor;
Meer, P B van der;
Boele, F W;
Reijneveld, J C;
Taphoorn, M J B;
Furth, W R van;
Dirven, L;
Peerdeman, S M;
Group, The Netherlands Meningioma Research

Publication type:

Article

OS4.2 The long-term disease burden of meningioma patients: results on health-related quality of life, cognitive function, anxiety and depression.

Published in:

Neuro-Oncology, 2018, v. 20, p. iii222, doi. 10.1093/neuonc/noy139.027

By:

Najafabadi, A H Zamanipoor;
Meer, P B van der;
Boele, F W;
Reijneveld, J C;
Taphoorn, M J B;
Klein, M;
Furth, W R van;
Dirven, L;
Peerdeman, S M;
Group, The Netherlands Meningioma Research

Publication type:

Article